Patient Number | SUV-MAX baseline | SUV-MAX week 1 | Absolute difference (ΔSUV-MAX) | Relative difference ΔSUV-MAX%)) | TRG | Presence of pCR |
---|---|---|---|---|---|---|
1 | 17.6 | 12 | −5.6 | −31.82 | III | no |
2 * | 42 | 23 | −19 | −45.24 | IV | no |
3 | 21.3 | 19.4 | −1.9 | −8.92 | I | yes |
4 | 17 | 13 | −4 | −23.53 | III | no |
5 | 16.7 | 9.5 | −7.2 | −43.11 | I | yes |
6 | 17.8 | 13.5 | −4.3 | −24.16 | III | no |
7 | 13 | 18.5 | 5.5 | 42.31 | II | no |
8 | 15.2 | 15.2 | 0 | 0.00 | II | no |
9 | 20 | 13.4 | −6.6 | −33.00 | IV | no |
10 | 56 | 37.9 | −18.1 | −32.32 | I | yes |
11 | 23 | 26 | 3 | 13.04 | III | no |
12 | 28 | 36 | 8 | 28.57 | III | no |
13 | 18.2 | 15.4 | −2.8 | −15.38 | III | no |
14 | 16.9 | 13.7 | −3.2 | −18.93 | III | no |
15 | 11.9 | 9.7 | −2.2 | −18.49 | IV | no |
16 | 8.9 | 6.2 | −2.7 | −30.34 | IV | no |
17 | 7.5 | 13.9 | 6.4 | 85.33 | IV | no |
18 | 15.2 | 12.4 | −2.8 | −18.42 | III | no |
19 | 24.6 | 25 | 0.4 | 1.63 | III | no |
20 | 9.4 | 5.8 | −3.6 | −38.30 | I | yes |